Skip to content
Screener

Revvity RVTY Financing Cash Flow

Financing Cash Flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$1.57B-58.5%
Danaher logo
DanaherDHR
$7.27B+3,045%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
-$75.8M-781%
WAT
Waters CorporationWAT
-$123M-9,547%
Agilent Technologies logo
Agilent TechnologiesA
-$144M-24.1%
Illumina logo
IlluminaILMN
-$129M+65.2%

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$12.83B+28.7%
Enterprise value$15.91B+28.6%
P/E53.5×+18.6×
P/S4.4×+0.9×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Revvity’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000031791-26-000019
Line itemThree Months Ended / April 5,2026Three Months Ended / March 30,2025
Payments of debt financing issuance costs(2,402)
Payments of other credit facilities(50)
Payments for acquisition-related contingent consideration(1,817)
Proceeds from issuance of common stock under stock plans5,4412,632
Purchases of common stock(86,496)(153,594)
Dividends paid(7,840)(8,433)
Net cash used in financing activities(88,895)(163,664)
Effect of exchange rate changes on cash, cash equivalents and restricted cash(7,627)16,122

Item 1.Unaudited Financial Statements

FAQ

What is Revvity's financing cash flow?
Revvity (RVTY) reported financing cash flow of -$88.9M in Q1 2026.
How has Revvity's financing cash flow changed year-over-year?
Revvity's financing cash flow increased by 45.7% year-over-year, from -$163.66M to -$88.9M.
What is the long-term trend for Revvity's financing cash flow?
Over 3 years (2022 to 2025), Revvity's financing cash flow has grown at a 9.0% compound annual growth rate (CAGR), from -$661.8M to -$857.52M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Revvity's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude